Purchases and Sales Made in Q1 2025 in Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN) during Q1 2025. The information is specifically focused on institutions that hold shares of NeuroSense Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 07, 2025
Q1 2025
|
Hurley Capital, LLC
New York, NY |
BUY
|
- |
8.71KNew |
$8.1K - $10.5K
|
8.71K
$16.5K
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
BUY
|
- |
2.28KNew |
$2.12K - $2.75K
|
2.28K
$4.32K
|
|
|
May 09, 2025
Q1 2025
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
1K+ 6.15% |
$930 - $1.21K
|
17.3K
$32.8K
|
|
|
May 14, 2025
Q1 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2025
Q1 2025
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-312- 2.08% |
$290 - $378
|
14.7K
$27.9K
|
|
|
May 07, 2025
Q1 2025
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-8.19K- 19.55% |
$7.62K - $9.91K
|
33.7K
$64K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-52.1K- 50.77% |
$48.4K - $63K
|
50.5K
$96K
|